Psychopharmacology and Psychiatry Updates

243 Episodo

1. Subclinical Hypothyroidism in Depressed Adolescents

   Publicado: 18/11/2021
2. Principles for Managing Alcohol Use Disorder

   Publicado: 13/11/2021
3. ECT for Depressed Patients With Borderline Personality Disorder

   Publicado: 8/11/2021
4. Assessing and Treating Alcohol Withdrawal

   Publicado: 3/11/2021
5. Lab Tests in Psychopharmacology

   Publicado: 29/10/2021
6. Technology-Facilitated Adherence Enhancement and Family Involvement

   Publicado: 24/10/2021
7. Drug-Induced Hyperthermic Syndromes in Psychiatry

   Publicado: 19/10/2021
8. How to Improve Adherence: Targeting Reasons for Nonadherence

   Publicado: 14/10/2021
9. Esketamine: Postmarketing Safety Concerns

   Publicado: 9/10/2021
10. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Publicado: 4/10/2021
11. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Publicado: 29/9/2021
12. How to Assess Psychotropic Drug Adherence

    Publicado: 24/9/2021
13. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Publicado: 19/9/2021
14. Delirium, Catatonia, and COVID-19

    Publicado: 14/9/2021
15. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Publicado: 9/9/2021
16. Dopamine and Depression: Clinical Considerations

    Publicado: 4/9/2021
17. Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium

    Publicado: 30/8/2021
18. New Somatic Treatments for Child and Adolescent Depression

    Publicado: 25/8/2021
19. Management of Delirium: Nonpharmacologic Strategies

    Publicado: 20/8/2021
20. Emerging Complementary and Integrative Therapies for Geriatric Mental Health

    Publicado: 15/8/2021